A detailed history of Logos Global Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 800,000 shares of AKRO stock, worth $24.5 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares
800,000
Previous 800,000 -0.0%
Holding current value
$24.5 Million
Previous $18.8 Million 22.29%
% of portfolio
3.04%
Previous 1.76%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$11.38 - $50.33 $2.28 Million - $10.1 Million
200,000 Added 33.33%
800,000 $18.7 Million
Q3 2023

Nov 14, 2023

BUY
$41.19 - $52.25 $3.3 Million - $4.18 Million
80,000 Added 15.38%
600,000 $30.3 Million
Q2 2023

Aug 14, 2023

BUY
$36.89 - $56.88 $4.43 Million - $6.83 Million
120,000 Added 30.0%
520,000 $24.3 Million
Q3 2022

Nov 14, 2022

BUY
$10.15 - $34.05 $4.06 Million - $13.6 Million
400,000 New
400,000 $13.6 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.42B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.